Mito Health Focuses on Prevention First Not Just Treatment

Six in ten adults suffer from a chronic illness in the US, yet much of the country’s healthcare system remains reactive which means they are designed to treat ailments after they arise rather than preventing them in the first place. Mito Health, founded by Teeming Chew, Joel Kek, Kenneth Lou, and Ryan Ware, a San Francisco-based AI-driven health company, is attempting to shift the focus toward proactive prevention. With a new $2.2 million infusion of seed funding, the company has now raised a total of $4 million.

Founded on the principle that early detection and personalized intervention can dramatically alter long-term health outcomes, Mito Health employs AI to analyze extensive health data. By integrating over 100 biomarkers, past medical records, and lifestyle factors, Mito Health creates tailored health optimization plans for its users. These insights guide individuals in adjusting their diet, exercise routines, supplement intake, and sleep patterns to improve their overall health and longevity.

_{Credits: Mito Health}

Since its launch in San Francisco last summer, Mito Health has expanded nationwide, forming key partnerships with leading laboratories such as LabCorp and BioReference. Its approach goes beyond simple biomarker analysis; it connects various health metrics, lifestyle factors, and personal medical history into a cohesive plan tailored to each user. The company’s platform has already demonstrated its effectiveness: